Filing Details
- Accession Number:
- 0001171843-21-003938
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-01 16:43:37
- Reporting Period:
- 2021-06-01
- Accepted Time:
- 2021-06-01 16:43:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1684144 | Zomedica Corp. | ZOM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1815574 | Robert Cohen | C/O Zomedica Corp. 100 Phoenix Drive, Suite 125 Ann Arbor MI 48108 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Without Par Value | Acquisiton | 2021-06-01 | 2,000,000 | $0.19 | 2,000,000 | No | 4 | M | Direct | |
| Common Stock, Without Par Value | Acquisiton | 2021-06-01 | 1,193,750 | $0.23 | 3,193,750 | No | 4 | M | Direct | |
| Common Stock, Without Par Value | Disposition | 2021-06-01 | 3,193,750 | $0.81 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Without Par Value | Stock option (right to buy) | Disposition | 2021-06-01 | 2,000,000 | $0.00 | 2,000,000 | $0.19 |
| Common Stock, Without Par Value | Stock option (right to buy) | Disposition | 2021-06-01 | 1,193,750 | $0.00 | 1,193,750 | $0.23 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-06-16 | No | 4 | M | Direct | |
| 10,806,250 | 2030-12-30 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17, 2021.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.80 to $0.8499 per share, inclusive. The Reporting Person undertakes to provide to Issuer any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- Options fully vested.
- The option vests as to 50% of the shares on December 31, 2020 with the remainder in 2 equal annual installments commencing December 31, 2021.
Billionaire Hedge Funds
